---
abstract: ''
authors:
- Ebell, Mark
category: Clinical Review
clinical_significance: High
cme_credits: 0.0
doi: ''
evidence_level: ''
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38215431/
file_path: 2023/12/terbinafine-250-mg-once-daily-12-weeks-on-12-weeks-off-four.md
issue: '6'
keywords:
- Antifungal Agents
- Terbinafine
- Humans
- Adult
- Treatment Outcome
- Onychomycosis
- Foot Dermatoses
last_updated: '2025-08-09'
mesh_terms:
- Adult
- Humans
- Terbinafine
- Onychomycosis
- Antifungal Agents
- Treatment Outcome
- Foot Dermatoses
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '38215431'
processed_date: '2025-08-09'
publication_date: '2023-12-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 1
source: American family physician
specialties:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Terbinafine, 250 mg Once Daily-12 Weeks on, 12 Weeks off, Four Weeks on-Is
  Preferred for Onychomycosis in Adults.
topics:
- Family Medicine
volume: '108'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '38215431'
  title: Terbinafine, 250 mg Once Daily-12 Weeks on, 12 Weeks off, Four Weeks on-Is
    Preferred for Onychomycosis in Adults.
  authors:
  - last_name: Ebell
    fore_name: Mark
    initials: M
    affiliation: University of Georgia, Athens, Ga.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '108'
    issue: '6'
  publication_info:
    year: '2023'
    month: '12'
    full_date: '2023-12-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Adult
    major_topic: false
  - descriptor: Humans
    major_topic: false
  - descriptor: Terbinafine
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Onychomycosis
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Antifungal Agents
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Treatment Outcome
    major_topic: false
  - descriptor: Foot Dermatoses
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '38215431'
  title: Terbinafine, 250 mg Once Daily-12 Weeks on, 12 Weeks off, Four Weeks on-Is
    Preferred for Onychomycosis in Adults.
  authors:
  - name: Ebell M
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Dec
- pmid: '11385230'
  title: Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole
    in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
  authors:
  - name: Gupta AK
    authtype: Author
    clusterid: ''
  - name: Gregurek-Novak T
    authtype: Author
    clusterid: ''
  source: Dermatology
  pubdate: '2001'
- pmid: '37801521'
  title: Comparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy
    in Patients With Onychomycosis.
  authors:
  - name: Saleem MA
    authtype: Author
    clusterid: ''
  - name: Shah RR
    authtype: Author
    clusterid: ''
  - name: Sharif S
    authtype: Author
    clusterid: ''
  - name: Rana D
    authtype: Author
    clusterid: ''
  - name: Waqas N
    authtype: Author
    clusterid: ''
  - name: Rao BK
    authtype: Author
    clusterid: ''
  source: J Drugs Dermatol
  pubdate: 2023 Oct 1
- pmid: '9529685'
  title: Long-term follow up of patients with toenail onychomycosis after treatment
    with terbinafine.
  authors:
  - name: Watson AB
    authtype: Author
    clusterid: ''
  - name: Marley JE
    authtype: Author
    clusterid: ''
  - name: Ellis DH
    authtype: Author
    clusterid: ''
  - name: Williams TG
    authtype: Author
    clusterid: ''
  source: Australas J Dermatol
  pubdate: 1998 Feb
- pmid: '11359413'
  title: Oral terbinafine treatment for toenail onychomycosis.
  authors:
  - name: De Berker D
    authtype: Author
    clusterid: ''
  source: Br J Dermatol
  pubdate: 2001 May
---

# Terbinafine, 250 mg Once Daily-12 Weeks on, 12 Weeks off, Four Weeks on-Is Preferred for Onychomycosis in Adults.

**Authors:** Ebell, Mark

**Published in:** American family physician | Vol. 108, No. 6 | 2023-12-01

**Links:** [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38215431/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Adult, Humans, Terbinafine, Onychomycosis, Antifungal Agents, Treatment Outcome, Foot Dermatoses

## Article Content

# Terbinafine, 250 mg Once Daily-12 Weeks on, 12 Weeks off, Four Weeks on-Is Preferred for Onychomycosis in Adults.

**Authors:** Ebell, Mark

**Published in:** American family physician | Vol. 108, No. 6 | 2023-12-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38215431/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Adult, Humans, Terbinafine, Onychomycosis, Antifungal Agents, Treatment Outcome, Foot Dermatoses

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38215431/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38215431/) (reference)

---

*Processed: 2025-08-09* | *PubMed Enhanced: 2025-07-30*
